Beneficial microbiota modifications in patients experiencing response to ICB after FMT resulted in the enrichment of CD8 T cells infiltrating the tumor and contacting melanoma cells as well as an increase in circulating ICOS+CD8+ T cells (18). The gene discussed is CD8A; the disease is melanoma.